PANACEA BIOTEC LTD. - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Details of Shares dematerialized during October, 2019 is enclosed herewith.07-11-2019
07-11-2019
PANACEA BIOTEC LTD. - 531349 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation to our letter dated November 05,2019 intimating the date of proposed Board Meeting scheduled to to be held on November 14, 2019, for approving the Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter and half year ended September 30, 2019 and pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith newspaper copies of the notice of Board Meeting published in the following newspapers on November 06,2019:- Business Standard (English); Desh Sewak (Punjabi)06-11-2019
Panacea Biotec Ltd - 531349 - Board Meeting Intimation for Approving The Standalone And Consolidated Unaudited Financial Results (Provisional) For The Quarter And Half Year Ended September 30, 2019
PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter and half year ended September 30, 2019. Further, pursuant to Regulations 46(2) & 47(1) of the SEBI LODR Regulations, notice of the said meeting is also being sent for publication in newspapers and uploaded on the website of the Company. Further, with reference to our earlier announcement dated September 28, 2019 intimating the Closure of Trading Window pursuant to the Company's Code of Conduct for Prevention of Insider Trading under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform that the trading window of the Company shall remain closed for all Designated Persons of the Company and Material Subsidiaries of the Company till November 16, 2019. This is for your kind information and record please.05-11-2019
Panacea Biotec Ltd - 531349 - Disclosure Of Reasons For Encumbrance Under Regulation 31(1) Read With Regulation 28(3)Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations, 2011
With reference to the SEBI Circular No. SEBI/HO/CFD/DCR1/CIR/P/2019/90 dated August 07, 2019 on the captioned subject, please find enclosed herewith the necessary disclosure for your information and record. Kindly take the same on record and acknowledge receipt.19-10-2019
PANACEA BIOTEC LTD. - 531349 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on October 19, 2019 for Sandeep Jain & Others19-10-2019
PANACEA BIOTEC LTD. - 531349 - Certificate Pursuant To Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Half-Year Ended September 30, 2019
Pursuant to the provisions of Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the certified copy of certificate from M/s. R & D, Company Secretaries, for the half-year ended September 30, 2019, confirming that all the transfers of shares have been completed within the stipulated time. This is for your kind information and record please.18-10-2019
PANACEA BIOTEC LTD. - 531349 - Shareholding for the Period Ended September 30, 2019
Panacea Biotec Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here17-10-2019
PANACEA BIOTEC LTD. - 531349 - Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Vinod GoelDesignation :- Company Secretary and Compliance Officer17-10-2019
Panacea Biotec Ltd - 531349 - Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 For The Half-Year Ended On 30Th September, 2019
Pursuant to the provisions of Regulation 7(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we are enclosing herewith the certificate duly signed by Skyline Financial Services Pvt. Ltd., Share Transfer Agent and Company Secretary of Panacea Biotec Ltd. for the half year ended on 30th September, 2019 in compliance of Regulation 7(2) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations,2015.14-10-2019
Panacea Biotec Ltd - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith a certificate dated October 09, 2019, issued by Skyline Financial Services Private Limited, Registrar and Transfer Agent of the Company, confirming compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2019. This is for your kind information and record please.10-10-2019